GLOBAL CANCER TECHNOLOGY INC
Global Cancer Technology Inc is a non-revenue medical technology holding company based in San Diego.
GLOBAL CANCER TECHNOLOGY INC
Social Links:
Industry:
Health Care Medical Medical Device Pharmaceutical
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.globalcancertechnology.com
Total Employee:
1+
Status:
Active
Contact:
+1 (858) 451-6173
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager WordPress Font Awesome Wordpress Plugins
Similar Organizations
Artes Medical
Artes Medical is a medical technology company focused on developing, manufacturing.
Polymer Technology Systems, Inc
Polymer Technology Systems is a medical device company specializing in diagnostics solutions.
Current Employees Featured
Founder
Official Site Inspections
http://www.globalcancertechnology.com
- Host name: 120.205.167.72.host.secureserver.net
- IP address: 72.167.205.120
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260

More informations about "Global Cancer Technology Inc"
Global Cancer Technology - LinkedIn
Global Cancer Technology | 472 followers on LinkedIn. ... Glioblastoma Research Organization Philanthropic Fundraising Services Miami, FL Glioblastoma Foundation Philanthropy Durham, North ...See details»
Global Cancer Technology Inc - Crunchbase
View contacts for Global Cancer Technology Inc to access new leads and connect with decision-makers. View All Contacts . Details. Edit Details Section. Industries . Health Care . Medical . ... 4,383 Number of Organizations • $61.5B …See details»
Global Cancer Technology - Overview, News & Similar ... - ZoomInfo
Global Cancer Technology is a biopharma company focused on developing a novel treatment for cancers, including glioblastoma, through its unique radioactivated drug transport technology. …See details»
Global Cancer Technology Company Profile | Management and
Global Cancer Technology Profile and History. About Global Cancer Technology: a non-revenue medical technology company currently conducting a Reg CF funding effort through NetCapital, …See details»
Global Cancer Technology - Netcapital
Feb 25, 2020 Global Cancer Technology (“GCT”) is an emerging medical technology company with numerous patents and other IP that might lead to breakthroughs in cancer therapy. The company is partnering with highly …See details»
Global Cancer Technology - EquityNet
Global Cancer Technology (GCT) is an emerging biopharmaceutical company that is pre-revenue and financially operates as a medical technology holding company. GCT holds numerous patents and other assets including licenses to …See details»
Global Cancer Technology - Products, Competitors, Financials, …
Oct 18, 2023 GLOBAL CANCER TECHNOLOGY RECEIVES INITIAL PRE-CLINICAL RESULTS OF GCT-007 IN PSORIASIS. Oct 18, 2023. News Provided By Share This Article …See details»
Global Cancer Technology, Inc - nationalinvestornetwork.com
Global Cancer Technology was formed to acquire a portfolio of various medical licenses for unique and promising patents and intellectual properties. The company has acquired licenses …See details»
Global Cancer Technology - The Org
Global Cancer Technology 0 followers Exclusive licensee of innovative technologies from USCD Moores Cancer Center and other leading cancer-fighting institutions.See details»
Global Cancer Technology - VentureRadar
Global Cancer Technology is a pioneering biopharma company dedicated to developing innovative treatments for cancer, with a focus on glioblastoma brain cancer. The company's …See details»
Global Cancer Technology, Inc. - Drug pipelines, Patents, Clinical ...
Explore Global Cancer Technology, Inc. with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Neoplasms, Technology Platform:Chemical drugs ...See details»
GLOBAL CANCER TECHNOLOGY LLC - Dun & Bradstreet
Global cancer technology llc. d&b business directory home / business directory / health care and social assistance / social assistance / individual and family services / united states / texas / …See details»
Global Cancer Technology - PitchBook
Sep 8, 2021 Global Cancer Technology General Information Description. Operator of a non-revenue biopharma company intended to develop a potent and selective PI3K …See details»
Global Cancer Technology Overview | SignalHire Company Profile
Global Cancer Technology is a private company that has been in the industry for 11 years. The company currently specializes in the Nanotechnology area. ... To connect with Global Cancer …See details»
Global Cancer Technology Inc - Contacts, Employees, Board …
Global Cancer Technology Inc is a non-revenue medical technology holding company based in San Diego. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log …See details»
Global Cancer Technology | Manhattan Street Capital
Global Cancer Technology (GCT) CEO and founder, John Clark, was recently interviewed by Proactive Investors Online regarding GCT's atypically fast SEC approval for a Reg A+ shares …See details»
Global Cancer Technology Appoints Chief Scientific Consultant …
Jun 2, 2021 Global Cancer Technology (GCT) is an emerging biopharmaceutical company that is pre-revenue and financially operates as a medical technology holding company. GCT holds …See details»
Global Cancer Technology | San Diego CA - Facebook
Aug 24, 2023 Global Cancer Technology, San Diego, California. 66 likes. PRODUCTS, PARTNERSHIPS AND SERVICES FOR THE WORLD-WIDE MEDICAL AND ONCOLOGY …See details»
Global Cancer Technology Removes its First Gamma Knife™ from ...
Global Cancer Technology is an international medical company providing radiosurgery equipment, partnerships, and services on a world-wide basis. Ad Statistics Times Displayed: 1084475See details»
Global Cancer Technology - Facebook
May 23, 2022 “In this public offering, the company is offering up to 3,500,000 shares of our common stock at $2.00 per share and our selling shareholders are offering 1,043,788 shares …See details»